ABSTRACT
Objective:To investigate the IRF5 rs2004640,rs10954213,rs4728142 loci gene polymorphisms in the progress of Systemic lupus erythematosus(SLE),and explore the influence of the IRF5 gene polymorphisms to the SLE.Methods:218 patients with SLE and 200 health controls were analyzed by using TaqMan-PCR.And all allele frequencies were calculated.The risk factors were compared between cases and controls.At the same time,antinuclear antibodies and double-stranded DNA antibody of 218 SLE cases were analysed with indirect immunefluorescence method,specific autoantibodies in plasma spectrometry were determined using linear immunoassay in plasma.Results:T allele frequency of IRF5 rs2004640 loci in SLE was higher than the controls,allele frequency of the G/T distribution differences in two groups were statistically significant(χ2=6.809,P=0.009).The GG/TT genotype frequencies between the control and the SLE were statistically significant(χ2=5.111,5.035;P=0.024,0.025).Compared control group with SLE group,G allele frequency of IRF5 rs10954213 loci in SLE group was higher than the controls,the difference was statistically significant(χ2=4.332,P=0.037).And GG genotype distribution had significant difference in the two groups(χ2=5.805,P=0.016).SLE group AA/AG/GG genotype distribution of IRF5 rs4728142 loci,compared with control group,there were no statistically difference(χ2=1.273,0.902,1.853;P=0.259,0.342,0.173).And allele frequency A/G also were not statistically differences in two groups(χ2=2.651,P=0.104).The T allele frequency of IRF5 rs2004640 and autoantibodies(anti-Sm,anti-Rib-P)significant associations were found with SLE patient.There were no statistically significant difference between IRF5 rs10954213 with autoantibodies.Compared with SLE remission patients,ANA,ds-DNA increased obviously.Anti-NUC,anti-His,anti-Rib-P were higher,there were statistically significant differences betwen two groups.Conclusion:The GG/GT/TT polymorphism of IRF5 rs2004640,GG/GA/AA polymorphism of rs10954213 were related to SLE.But the GG/GA/AA polymorphism of IRF5 rs4728142 were not significant difference.IRF5 rs2004640 T comtributed to the anti-Sm,anti-Rib-P.In active SLE patients,anti-ds-DNA,anti-NUC,anti-His,anti-Rib-P were higher than the other group.
ABSTRACT
Las anemias diseritropoyéticas congénitas (ADC) son un grupo de trastornos heridatarios de la hematopoyesis caracterizados por anemia refractaria de severidad variable. Se distinguen 3 tipos fundamentales: 1, 2 y 3. El gen responsable de la ADC-1 (CDAN1) se localiza en el cromosoma 15q15, aunque estudios moleculares recientes evidencian la heterogeneidad de esta enfermedad. Se presenta una paciente de 3 años con diagnóstico de ADC-1 que a los 3 meses de edad comenzó con anemia severa, hiperbilirrubinemia indirecta, reticulocitosis ligera, altos requerimientos transfusionales y alteraciones del desarrollo pondoestatural dado por baja talla. La prueba de Ham fue negativa y en sangre periférica predominó la macrocitosis. En el examen de la médula ósea se observó diseritropoyesis con hiperplasia eritroide, hematopoyesis megaloblástica, precipitados intracitoplasmáticos, núcleos irregulares, cariorrexis, binuclearidad y puentes internucleares. No hubo respuesta al tratamiento con interferón alfa recombinante. La paciente se encuentra con tratamiento quelante con deferroxamina y se ha planteado la posibilidad de un trasplante de células progenitoras hematopoyéticas alogénico no relacionado
The congenital dyserytropoietic anemias (CDT) include a series of hematopoiesis hereditary disorders characterized by a refractory anemia of variable severity. There are three fundamental types: 1, 2 and 3. The gen accounted for CDT-1(CDAN1) is located in 15q15 chromosome, although recent studies demonstrate the heterogeneity of this disease. This is the case of a female patient aged 3 diagnosed with CDT-1who at three months old had a severe anemia, indirect hyperbilirubinemia, slight reticulocytosis, high transfusion requirements and stature disorders due to its low height. Hams was negative and in peripheral blood there was macrocytosis predominance. Bin bone marrow examination it was possible to observe dyserytropoiesis with erythroid hyperplasia, megaloblast hematopoiesis, intracytoplasm precipitates, irregular nuclei, karyorresis, binuclearization and internuclear bridges. There wasnt response to treatment with the recombinant type α interferon. Patient is under chelation treatment with deferoxamine and it was proposed the possibility of no-related allogenic of hematopoietic parent cell